Growth Metrics

Armata Pharmaceuticals (ARMP) Net Income towards Common Stockholders Growth (1y) (2016 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -58.11%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -95.76%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -290.15%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 59.59%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -10.08%
8 Evaxion A 65.12 Bn 65.10 Bn - -129.68%
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 1,228.66%
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -883.01%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -883.01%
Dec 31, 2025 -35.01%
Sep 30, 2025 4.39%
Jun 30, 2025 -13.07%
Mar 31, 2025 53.10%
Dec 31, 2024 -26.07%
Sep 30, 2024 -10.59%
Jun 30, 2024 -50.38%
Mar 31, 2024 -120.88%
Dec 31, 2023 -6.27%
Sep 30, 2023 -33.10%
Jun 30, 2023 -3.99%
Mar 31, 2023 -29.11%
Dec 31, 2022 -70.56%
Sep 30, 2022 -40.18%
Jun 30, 2022 -48.77%
Mar 31, 2022 -59.67%
Dec 31, 2021 7.72%
Sep 30, 2021 -6.52%
Jun 30, 2021 -31.51%
Mar 31, 2021 -8.21%
Dec 31, 2020 -42.89%
Sep 30, 2020 17.05%
Jun 30, 2020 -12.17%
Mar 31, 2020 -40.39%
Dec 31, 2019 48.54%
Sep 30, 2019 -327.47%
Jun 30, 2019 -37.67%
Mar 31, 2019 -15.41%
Dec 31, 2018 -282.49%
Sep 30, 2018 -108.86%
Jun 30, 2018 62.07%
Mar 31, 2018 3.45%
Dec 31, 2017 75.47%
Sep 30, 2017 78.29%
Jun 30, 2017 -26.63%
Mar 31, 2017 32.89%
Dec 31, 2016 -198.74%
Sep 30, 2016 -108.18%
Jun 30, 2016 -171.02%